You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Details for Patent: 8,536,163


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,536,163 protect, and when does it expire?

Patent 8,536,163 protects PICATO and is included in one NDA.

This patent has thirty-three patent family members in twenty-one countries.

Summary for Patent: 8,536,163
Title:Therapeutic compositions
Abstract: Ingenol angelate is a potent anticancer agent, and can be stabilized by dissolving it in an aprotic solvent in the presence of an acidic buffer.
Inventor(s): Brown; Marc Barry (Watford, GB), Crothers; Michael (Hillsborough, GB), Nazir; Tahir (Isleworth, GB)
Assignee: LEO Laboratories Limited (Dublin, IE)
Application Number:13/769,821
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,536,163
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 8,536,163

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Leo Labs PICATO ingenol mebutate GEL;TOPICAL 202833-001 Jan 23, 2012 DISCN Yes No ⤷  Sign Up ⤷  Sign Up USE OF INGENOL MEBUTATE TO TREAT ACTINIC KERATOSIS ⤷  Sign Up
Leo Labs PICATO ingenol mebutate GEL;TOPICAL 202833-002 Jan 23, 2012 DISCN Yes No ⤷  Sign Up ⤷  Sign Up USE OF INGENOL MEBUTATE TO TREAT ACTINIC KERATOSIS ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,536,163

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0525680.5Dec 16, 2005

International Family Members for US Patent 8,536,163

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1988877 ⤷  Sign Up C300682 Netherlands ⤷  Sign Up
European Patent Office 1988877 ⤷  Sign Up PA2014030 Lithuania ⤷  Sign Up
European Patent Office 1988877 ⤷  Sign Up CA 2014 00042 Denmark ⤷  Sign Up
European Patent Office 1988877 ⤷  Sign Up C20140025 00111 Estonia ⤷  Sign Up
European Patent Office 1988877 ⤷  Sign Up C01988877/01 Switzerland ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.